As the weather turns cold, chaga shows up everywhere: in tea bags, “mushroom coffee” blends, tinctures, and powders promising immune support and antioxidant power. It has a genuine folk history, especially in Russia, Siberia, and Scandinavia, where it was brewed as a tea substitute for generations.
The marketing has run well ahead of the science, though. This brief covers what chaga is, what has actually been studied, and one safety issue that rarely makes it onto the label.
What chaga is
Chaga (Inonotus obliquus) is not a typical mushroom with a cap and stem. What gets harvested is a hard, black, cracked mass called a sterile conk that grows mostly on birch trees in cold northern forests. It looks like burnt charcoal on the outside and has a rusty orange interior.
Because it grows on birch, chaga absorbs compounds from the tree, including betulin and betulinic acid. It also contains:
- Polysaccharides, including beta-glucans, which are the focus of most immune-related mushroom research
- Polyphenols and melanin pigments, which give chaga its dark color and high antioxidant readings in lab tests
- Triterpenes such as inotodiol and lanosterol
For broader context on how chaga compares to reishi, lion’s mane, and others, see our medicinal mushrooms guide.
What the research shows
Mostly lab and animal studies
The large majority of chaga research has been done in cell cultures and animals. In those settings, chaga extracts have shown antioxidant activity, effects on immune-cell signaling, anti-inflammatory activity, and blood-sugar-lowering effects in diabetic rodents.
Those findings are a reasonable starting point for research, but they do not tell us what happens when a person drinks chaga tea. Effects seen when cells are bathed directly in an extract often do not survive digestion, absorption, and real-world doses. Many promising compounds fail at exactly this step.
Very few human trials
Controlled human trials of chaga are close to nonexistent. There is no established effective dose, no reliable data on how well its compounds are absorbed, and no long-term safety data from trials. That is the single most important fact about chaga, and it is easy to miss under the volume of marketing.
The antioxidant score problem
Chaga is often sold on its very high ORAC score, a test-tube measure of antioxidant capacity. A high ORAC number does not show that a food or supplement changes antioxidant status in the body or produces health benefits, which is why the U.S. Department of Agriculture withdrew its ORAC database. We cover this in detail in our ORAC myth post.
Beta-glucans: plausible, but not chaga-specific
Mushroom beta-glucans have the most human research of any mushroom compound, mostly from other species and from yeast and oat sources. Some studies suggest certain beta-glucans can influence immune signaling. Whether chaga supplies enough of the right types, in an absorbable form, to matter is not established. Our reishi research brief covers a mushroom with somewhat more human data, for comparison.
The safety issue: oxalate
Chaga is one of the highest-oxalate foods known, with lab analyses reporting oxalate levels far above spinach or rhubarb. Oxalate binds calcium and can contribute to calcium-oxalate kidney stones, and very high oxalate intake can deposit crystals in the kidney itself.
This is not just theoretical. Published case reports describe people who developed serious kidney injury (oxalate nephropathy) after consuming concentrated chaga powder daily for months. Case reports cannot tell us how common the problem is, but they show the risk is real at sustained, concentrated doses.
Practical takeaways:
- Avoid regular chaga use if you have a history of kidney stones, kidney disease, or conditions that increase oxalate absorption (such as some bowel diseases or past gastric bypass surgery).
- Concentrated powders and extracts taken daily are a bigger concern than an occasional cup of weak tea.
- Stack awareness: high-dose vitamin C can also raise oxalate in some people. See our post on vitamin C and kidney stones.
Other cautions and interactions
- Diabetes medications. Animal studies suggest blood-sugar lowering, so combining chaga with insulin or glucose-lowering drugs could add to the effect.
- Blood thinners and antiplatelet drugs. Lab data suggest chaga may inhibit platelet aggregation. Use caution with warfarin, aspirin, clopidogrel, and similar drugs, and stop before scheduled surgery.
- Autoimmune conditions and immunosuppressants. Because chaga is marketed as immune-stimulating, there is a theoretical concern for people with autoimmune disease or those on immunosuppressive medication. Data are lacking either way.
- Pregnancy and nursing. No safety data; avoid.
- Contaminants. Wild-harvested fungi can accumulate heavy metals from their environment. Choose brands with third-party testing.
Wild conk vs. myceliated grain
Many products labeled “chaga” are not the wild conk at all. They are mycelium grown on grain (often oats or rice) and then dried and ground with the grain. These products can be mostly starch, with far fewer of the compounds found in the wild sclerotium. Some labels say “mycelium on grain” or “myceliated brown rice” in small print.
Wild chaga also grows slowly, and heavy commercial harvesting has raised sustainability concerns in some regions. If you buy chaga, look for:
- The part used (sclerotium/conk vs. mycelium)
- Beta-glucan content measured by a specific method, not just total “polysaccharides,” which can include starch
- Third-party testing for contaminants
If you still want to try it
There is no evidence-based dose. Supplement labels commonly list 1-3 g per day of powder or extract, and traditional tea is made by simmering small chunks or powder in hot water. A reasonable cautious approach:
- Treat it as an occasional tea, not a daily concentrated supplement
- Keep courses short rather than taking it every day for months
- Drink plenty of fluid and do not combine it with other high-oxalate supplements
- Skip it entirely if any of the cautions above apply to you
If your interest is immune support during cold season, the fundamentals have far more evidence: sleep, vaccination, adequate protein, and correcting a measured vitamin D or zinc shortfall. Our immune supplement guide compares options by evidence strength.
Bottom line
Chaga has a long folk history and interesting chemistry in the lab, but almost no human clinical trials support its marketed benefits, and there is no established dose. Its very high oxalate content is a concrete risk, with case reports of kidney injury after months of daily concentrated use. If you enjoy it as an occasional tea and have no kidney, clotting, or blood-sugar concerns, that is a reasonable choice; treating it as a daily immune or antioxidant supplement is not supported by the evidence.
This article is educational and not medical advice. Consult a healthcare provider before starting any supplement, especially if you are pregnant, nursing, taking medication, or managing a health condition.